FLERIE Stock Overview
A venture capital firm specializing in early-stage investments. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Flerie AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 44.59 |
| 52 Week High | SEK 57.00 |
| 52 Week Low | SEK 40.01 |
| Beta | 0 |
| 11 Month Change | -1.96% |
| 3 Month Change | 2.51% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| FLERIE | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | -0.3% | -6.8% | -2.1% |
| 1Y | n/a | 8.0% | 10.8% |
Return vs Industry: Insufficient data to determine how FLERIE performed against the Swedish Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how FLERIE performed against the Swedish Market.
Price Volatility
| FLERIE volatility | |
|---|---|
| FLERIE Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 10.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: FLERIE has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: Insufficient data to determine FLERIE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Ted Fjallman | www.flerie.com |
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel.
Flerie AB (publ) Fundamentals Summary
| FLERIE fundamental statistics | |
|---|---|
| Market cap | SEK 3.51b |
| Earnings (TTM) | SEK 0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs FLERIE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FLERIE income statement (TTM) | |
|---|---|
| Revenue | SEK 0 |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 0 |
| Other Expenses | SEK 0 |
| Earnings | SEK 0 |
Last Reported Earnings
n/a
Next Earnings Date
Jan 22, 2025
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did FLERIE perform over the long term?
See historical performance and comparison